Details of issuance or disposal
Issuance of Series 6 Stock Acquisition Rights (with Exercise Price Adjustment Clause) and Series 7 Stock Acquisition Rights (with Exercise Price Adjustment Clause) through a third-party allotment
Total potential shares: 1,500,000 (Series 6: 750,000; Series 7: 750,000)
¥15,000,000
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of Series 6 Stock Acquisition Rights (with Exercise Price Adjustment Clause) and Series 7 Stock Acquisition Rights (with Exercise Price Adjustment Clause) through a third-party allotment |
| Number of shares to be issued or disposed of | Total potential shares: 1,500,000 (Series 6: 750,000; Series 7: 750,000) |
| Issue price and disposal price | ¥1,800 per Series 6 Stock Acquisition Right and ¥200 per Series 7 Stock Acquisition Right |
| Total issue value | ¥15,000,000 |
| Amount of funds to be raised | ¥1,802,000,000 (¥15,000,000 from the issuance of the stock acquisition rights and ¥1,797,000,000 from the exercise of the stock acquisition rights; estimated net proceeds after deducting issuance expenses) |
| Payment date | 24 August 2026 |
| Intended allottee | Name SBI Securities / Type Securities company / Allotment details 7,500 Series 6 Stock Acquisition Rights, Name 東海東京証券 / Type Securities company / Allotment details 7,500 Series 7 Stock Acquisition Rights |
| Exercise price | The initial exercise price is ¥1,198 for both the Series 6 and Series 7 stock acquisition rights. It will be adjusted to 93% of the closing price on the trading day immediately preceding the effective date of each exercise request. The minimum exercise price is ¥718. There is no maximum exercise price. |
| Exercise period | 25 August 2026 to 24 August 2029 |
| Number of Stock Acquisition Rights | Total issued: 15,000 (Series 6: 7,500; Series 7: 7,500). Unexercised balance: Not disclosed. |
Items this document does not state (18)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Payment of the total issue price for the issuance of stock acquisition rights pursuant to the resolution of the Board of Directors dated 7 August 2026 has been completed.